Sunday, March 21, 2021 2:04:17 PM
Considering that they approved the inhaled ZYESAMI testing.. and they just announced that the first dosing of inhaled testing has been applied... And....considering that these test are being administered at some of the best and most highly respected facilities in the World, I can draw this possible and highly likely conclusion.
Could it not be concluded that there is absolutely no way they would approve and actually conduct an inhaled ZYESAMI trial if ZYESAMI had not been proven as highly effective for its purpose in the intravenous application of ZYESAMI?
Only my opinion, but if ZYESAMI was not effective in the first intravenous trial, I highly doubt that they would have approved an inhaled ZYESAMI trial.
Seems like that they absolutely know that it is a helpful therapeutic, but they are just trying to see if the application and benefit of ZYESAMI can be simplified and broadened.
Thanks for everyone's opinions and insight as we wait! GLTA!
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM